Jiangsu Recbio Technology Co., Ltd. - ROE
2179.HK
Price:
$4.405
Market Cap:
$1.99B
Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombina...[Read more]
Industry
Biotechnology
IPO Date
2022-03-31
Stock Exchange
HKSE
Ticker
2179.HK
PE Ratio
[-5.06]
ROE
[-79.24%]
Current Ratio
[0.53]
Dividend Yield
[0%]
Enterprise Value
[2.48B]
Dividend History
The ROE as of October 2026 (TTM) for Jiangsu Recbio Technology Co., Ltd. (2179.HK) is -79.24%
According to Jiangsu Recbio Technology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -79.24%. This represents a change of -4.26% compared to the average of -82.76% of the last 4 quarters.
Jiangsu Recbio Technology Co., Ltd. (2179.HK) Historical ROE (quarterly & annually)
How has 2179.HK ROE performed in the past?
The mean historical ROE of Jiangsu Recbio Technology Co., Ltd. over the last ten years is -37.91%. The current -79.24% ROE has changed 109.03% with respect to the historical average. Over the past ten years (40 quarters), 2179.HK's ROE was at its highest in in the June 2021 quarter at 32.74%. The ROE was at its lowest in in the June 2025 quarter at -191.77%.
Average
-37.91%
Median
-43.28%
Minimum
-106.25%
Maximum
43.27%
Jiangsu Recbio Technology Co., Ltd. (2179.HK) ROE by Quarter and Year
Discovering the peaks and valleys of Jiangsu Recbio Technology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.03%
Maximum Annual ROE = 43.27%
Minimum Annual Increase = -320.97%
Minimum Annual ROE = -106.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | -84.20% | -20.75% |
| 2024 | -106.25% | 99.03% |
| 2023 | -53.38% | 23.35% |
| 2022 | -43.28% | 10.13% |
| 2021 | -39.30% | -320.97% |
| 2020 | 17.78% | -58.90% |
Jiangsu Recbio Technology Co., Ltd. (2179.HK) Average ROE
How has 2179.HK ROE performed in the past?
The current ROE of Jiangsu Recbio Technology Co., Ltd. (2179.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-81.28%
5-year avg
-65.28%
10-year avg
-37.91%
Jiangsu Recbio Technology Co., Ltd. (2179.HK) ROE vs. Peers
How is 2179.HK’s ROE compared to its peers?
Jiangsu Recbio Technology Co., Ltd.’s ROE is greater than Clover Biopharmaceuticals, Ltd. (-64.89%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-32.32%), less than Antengene Corporation Limited (6.51%), greater than Cutia Therapeutics (-35.24%), greater than HighTide Therapeutics Inc (-114.28%), greater than AIM Vaccine Co., Ltd. (-24.66%), greater than Hua Medicine (Shanghai) Ltd. (-10.61%), greater than Zhaoke Ophthalmology Limited (-14.41%), greater than SinoMab BioScience Limited (-41.81%), less than Mabpharm Limited (48.25%),
| Company | ROE | Market cap |
|---|---|---|
| -64.89% | $2.39B | |
| -32.32% | $1.43B | |
| 6.51% | $2.30B | |
| -35.24% | $374.27M | |
| -114.28% | $1.85B | |
| -24.66% | $2.12B | |
| -10.61% | $2.30B | |
| -14.41% | $1.33B | |
| -41.81% | $1.40B | |
| 48.25% | $2.08B |
Build a custom stock screener for Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Recbio Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Jiangsu Recbio Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Jiangsu Recbio Technology Co., Ltd.'s ROE?
How is the ROE calculated for Jiangsu Recbio Technology Co., Ltd. (2179.HK)?
What is the highest ROE for Jiangsu Recbio Technology Co., Ltd. (2179.HK)?
What is the 3-year average ROE for Jiangsu Recbio Technology Co., Ltd. (2179.HK)?
What is the 5-year average ROE for Jiangsu Recbio Technology Co., Ltd. (2179.HK)?
How does the current ROE for Jiangsu Recbio Technology Co., Ltd. (2179.HK) compare to its historical average?